|
PDE4D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.82580003630306E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.05069999986907E-07 |
| Normal-vs-Stage2 |
6.770400E-02 |
| Normal-vs-Stage3 |
9.94219999661539E-08 |
| Normal-vs-Stage4 |
1.51989998364854E-09 |
| Stage1-vs-Stage2 |
3.442200E-01 |
| Stage1-vs-Stage3 |
1.595020E-01 |
| Stage1-vs-Stage4 |
3.240100E-02 |
| Stage2-vs-Stage3 |
1.025230E-01 |
| Stage2-vs-Stage4 |
4.420100E-02 |
| Stage3-vs-Stage4 |
5.882600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17690002188198E-09 |
| Normal-vs-AfricanAmerican |
2.954300E-02 |
| Normal-vs-Asian |
7.729000E-01 |
| Caucasian-vs-AfricanAmerican |
3.779000E-01 |
| Caucasian-vs-Asian |
2.045000E-01 |
| AfricanAmerican-vs-Asian |
2.471400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44740000382637E-09 |
| Normal-vs-Female |
2.61980000004769E-06 |
| Male-vs-Female |
3.322800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64240000000349E-05 |
| Normal-vs-Age(41-60Yrs) |
2.15429999994576E-06 |
| Normal-vs-Age(61-80Yrs) |
5.62169999440698E-09 |
| Normal-vs-Age(81-100Yrs) |
1.559730E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.215000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.814800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.476400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.248600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.176200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.919600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.239400E-01 |
| Normal-vs-Grade 2 |
2.39770000000084E-05 |
| Normal-vs-Grade 3 |
1.23860000034171E-08 |
| Normal-vs-Grade 4 |
7.4120000137512E-09 |
| Grade 1-vs-Grade 2 |
5.284800E-01 |
| Grade 1-vs-Grade 3 |
3.503000E-01 |
| Grade 1-vs-Grade 4 |
6.643900E-02 |
| Grade 2-vs-Grade 3 |
1.187190E-01 |
| Grade 2-vs-Grade 4 |
1.113550E-02 |
| Grade 3-vs-Grade 4 |
9.946000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.29840000000037E-05 |
| Normal-vs-ccB subtype |
8.90309999945771E-07 |
| ccA subtype-vs-ccB subtype |
2.787400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.3349999999912E-06 |
| Normal-vs-N1 |
2.118900E-03 |
| N0-vs-N1 |
5.572000E-01 |
|
|
